Login




Nefrologia clinica/Nefrologia pediatrica

The antibiotic empiric therapy in nephrological practice: our experience

Questo Abstract è stato accettato come Poster. Clicca qui per visualizzare

Razionale

Antibiotic resistance is a global problem today. The knowledge of bacterial resistances trend is crucial for antibiotic empiric therapy. Nephrological  practice meets several sites of microbiological interest. We aimed to study the prevalence of bacterial pathogens and their emerging resistance patterns to commonly used antibiotics.

Casistica e Metodi

We reviewed 1249 microbiologic reports obtained between January 2008 and December 2012 from patients admitted to Nephrology Department.   

The most frequent infection sites (total number 1249)

    Number

       %

Urine culture

        593

    47.5

Soft tissues

        134

     10.8

Peritoneal fluid

        109

     8.8

Bloodstream

        104

     8.4

Emergency skin

          68

      5.6

CVC-tip

          67

     5.4

PC-tip

          30

     2.4

Risultati

The most frequent among 1249 identified bacterial pathogens:

        Bacterial Pathogens

      number 

                   % 

1. Escherichia Coli

            241

                 19.3

2. Staphylococcus Aureus

            168

                 13.4

3. Enterococcus Faecalis

            156

                 12.5

4. Pseudomonas Aeruginosa

           107

                 8,6

5. Candida  

           103

                 8.2

6. Staphylococcus Epidermidis

            80

                 7.3

7. Klebsiella Pneumoniae

            75

                 6.0

8. Staphylococcus Haemoliticus

            30

                 2.4

9. Enterococcus Cloacae

            25

                 2.0

Conclusioni

We analyzed the antibiotic susceptibility patterns for the first 4 identified bacterial pathogens.   

Bacterial Pathogens

Positive versus total  antibiotic susceptibility tests

Escherichia Coli

 Imipenem: 237 / 237; meropenem 140/140,  colistin 121/121;  ertapenem 115/115; tigeciclina 112/113, 99.1%; amikacin 216/221, 97.7%

Staphylococcus Aureus

Linezolid: 163/163; mupirocin 130/130; tigecycline 102/102; teicoplanin and vancomycin 165/166, 99.4%; fusidic acid 163/165, 98.8%; daptomycin 73/74, 98.6%; trimethoprim /sulfamethoxazol 161/165, 97.6%; tobramycin 121/130, 93.1%; tetracycline 148/162, 91,4%.

Enterococcus Faecalis

 Teicoplanin 145/145; daptomycin 26/26; amoxicillin-clavulanic acid 93/94, 98.9%; vancomycin 143/145, 98.6%; ampicillin- sulbactam 120/122, 98.6%, imipenem 126/133, 94.7%, linezolid 127/140, 90.7%.

Pseudomonas Aeruginosa

Colistin: 107/107

Antibiotic resistance of bacterial pathogens to commonly used antibiotics is increasing. The surveillance of antimicrobial resistance is necessary. Our report on bacterial spectra of major antibiotic susceptibility patterns (Figure) enables a more rational use of antibiotics.

 

Luisa Bono, Gioacchino Li Cavoli, Carmela Zagarrigo, Franca Servillo, Mario Coglitore, Onofrio Schillaci, Angelo Tralongo, Calogero Tortorici, Angelo Ferrantelli, Carlo Giammarresi, Ugo Rotolo
(Nefrologia-Dialisi, ARNAS Civico e Di Cristina, Palermo)
Non sono presenti commenti
Figure
Realizzazione: TESISQUARE®

Per assistenza scrivere al Supporto Tecnico